Clinical Trials Browser

Breast Neoplasms, Radiodermatitis

NCT07192588 2025-09-25

GuARD

Phase 2 Active not recruiting

273 enrolled

Breast

Breast Neoplasms, Radiodermatitis

NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Phase 2 Completed

187 enrolled 11 charts

Breast

Breast Neoplasms, Inflammation, Radiodermatitis

NCT05693597 2024-02-23

Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients

Phase 2 Completed

132 enrolled

Breast

Breast Neoplasms, Radiodermatitis

NCT04149522 2023-11-08

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

Phase 2 Terminated

40 enrolled

Breast

Breast Neoplasms, Dermatitis, Eczema, Radiation Injuries, Radiodermatitis

NCT03716583 2021-09-10

MELADERM

Phase 2 Completed

48 enrolled

Breast

Breast Neoplasms, Radiodermatitis

NCT02556632 2017-11-06

Curcumin-II

Phase 2 Completed

191 enrolled 23 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Pain, Radiodermatitis

NCT02289365 2016-06-15

Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients

Phase 2 Unknown

120 enrolled

Breast

Breast Neoplasms, Radiodermatitis

NCT02249884 2015-12-02

DRCPTR

Phase 2 Completed

30 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Radiodermatitis

Clinical Trials

A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer

GuARD

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

MELADERM

Curcumin-II

Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients

DRCPTR